Guidelines for thyroid surgery published in Annals of Surgery

February 21, 2020

February 21, 2020 - The first set of comprehensive, evidence-based clinical guidelines for surgical treatment of thyroid disease - developed by an expert panel assembled by the American Association of Endocrine Surgeons (AAES) - was published today by Annals of Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.

The guidelines provide an expert perspective on current approaches to surgical management for patients with benign and malignant thyroid disease. "To help provide safe, effective, and appropriate care of patients, these AAES-sponsored multidisciplinary clinical guidelines analyze the conduct, indications, and outcomes of adult thyroid surgery guided by a comprehensive evidence-based review of the medical literature," according to the guideline statement. The lead author was Kepal N. Patel, MD, of NYU Langone Health, New York, N.Y.

Emphasis on Evidence-Based, Personalized Care for Patients Undergoing Thyroidectomy

The guidelines consist of a total of 66 specific recommendations, identified by a search of the medical literature from 1985 to 2018 and review by a multidisciplinary panel of 19 experts in thyroid disorders. Recommendations are graded according to the strength and quality of the supporting evidence; the full guidelines document provides guidance on how to best apply the recommendations to individual patients. The project was coordinated by Sally E. Carty, MD, of University of Pittsburgh School of Medicine and Christopher R. McHenry, MD, of Case Western Reserve University, Cleveland.

Thyroidectomy, referring to any type of thyroid surgery, is a common procedure - more than 100,000 thyroidectomies are performed each year in the United States. While thyroidectomy is "typically a definitive and often curative procedure," ongoing advances in diagnosis and management have led to variability and even controversy in the treatment of thyroid disease.

While other specialty societies have published recommendations addressing the management of thyroid nodules and thyroid cancer, the new AAES guidelines focus on surgical management of thyroid disease in adults. Specific objectives include:

On behalf of the AAES, the members of the expert panel hope their efforts will meet the need for evidence-based recommendations to "define practice, personalize care, stratify risk, reduce health care costs, improve outcomes, and identify rational challenges for future efforts." They conclude: "Throughout the writing process, [our] intent was to advise surgeons about the right thing to do for the patient" in need of surgical treatment for thyroid disease.

Click here to read "The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults." DOI: 10.1097/SLA.0000000000003580
-end-
About Annals of SurgeryAnnals of Surgery, the world's most highly referenced surgery journal, provides the international medical community with information on significant contributions to the advancement of surgical science and practice. Surgeons look to Annals of Surgery first for innovations in practice and technique. Special editorial features include "Advances in Surgical Technique," which provides up-to-the-minute coverage of current clinical issues, and monthly review articles that cover the most current practice concerns. The journal is affiliated with the American Surgical Association and the European Surgical Association.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit http://www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Wolters Kluwer Health

Related Thyroid Cancer Articles from Brightsurf:

Trends in the global burden of thyroid cancer
This study examined the worldwide trends of thyroid cancer from 1990 to 2017 according to geographic location, sex, age and socioeconomic factors.

Cancer treatment with immune checkpoint inhibitors may lead to thyroid dysfunction
Thyroid dysfunction following cancer treatment with new treatments called immune checkpoint inhibitors is more common than previously thought, according to research that was accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.

Thyroid cancer, genetic variations, cell phones linked in YSPH study
Radiation from cell phones is associated with higher rates of thyroid cancer among people with genetic variations in specific genes, a new study led by the Yale School of Public Health finds.

AJR researchers take step toward automating thyroid cancer triage
An article published ahead-of-print in the April issue of the American Journal of Roentgenology (AJR) details how a Stanford University team developed a quantitative framework able to sonographically differentiate between benign and malignant thyroid nodules at a level comparable to that of expert radiologists, which could provide second-opinion malignancy risk estimation to clinicians and ultimately help decrease the number of unnecessary biopsies and surgical procedures.

Thyroid cancer rates in US
An analysis suggests rates of thyroid cancer in the US appear to have plateaued in recent years after decades on the rise.

Using artificial intelligence to predict risk of thyroid cancer on ultrasound
New study uses machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.

For low-risk thyroid cancer patients, less may be more for post-surgery surveillance
Patient self-advocacy is important, and although a maximizing preference may be advantageous in many situations, new research led by the University of Michigan Rogel Cancer Center shows that, in the case of long-term surveillance of treated, low-risk thyroid cancer, health care ''maximizers'' consume more health care resources -- such as doctor visits and diagnostic imaging tests -- which drive up costs without a clear improvement in outcomes.

New test for thyroid cancer could prevent unnecessary surgery
Each year, thanks to inconclusive tests for thyroid cancer, thousands of people undergo unnecessary surgeries to remove part or all of their thyroids.

Raman spectroscopy poised to make thyroid cancer diagnosis less invasive
Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells.

Are doctors treating more thyroid cancer patients than necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.

Read More: Thyroid Cancer News and Thyroid Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.